Press release
Synairgen plc
('Synairgen' or the 'Company')
Notice of Annual Report and Accounts and Annual General Meeting
Southampton, UK - 8 October 2010: Synairgen plc (LSE: SNG), the respiratory drug discovery and development company with a particular focus on viral defence, announces that the Company's Annual Report and Accounts for the year ended 30 June 2010 has been posted to shareholders. A copy of the report can be found on the Company's website:
Synairgen's 2010 Annual General Meeting ('AGM') will be held at 12 noon on Wednesday 3 November 2010 at the offices of Fasken Martineau LLP, 17 Hanover Square, London W1S 1HU. The Notice of the AGM is included in the Annual Report and Accounts.
-Ends-
For further information, please contact:
Synairgen plc Tel: + 44 (0) 23 8051 2800
Richard Marsden, Chief Executive Officer
John Ward, Finance Director
Matrix Corporate Capital Tel: + 44 (0) 20 3206 7000
Alastair Stratton
James Gallagher
Threadneedle Communications Tel: + 44 (0) 20 7653 9850
Graham Herring
Josh Royston